Selective cyclooxygenase-2 inhibitors: pharmacology, clinical effects and therapeutic potential

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.5, 1997-05, pp. : 609-614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacology of Novel Selective COX-2 Inhibitors

Current Pharmaceutical Design, Vol. 10, Iss. 6, 2004-02 ,pp. : 589-601

Bentham Science Publishers

Access to resources Recommend Favorite

Selective inhibitors of cyclooxygenase-2

By Talley J.J.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 1, 1997-01 ,pp. : 55-62

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacology of Lumiracoxib: A Selective Cyclo-Oxygenase-2 Inhibitor

By Rordorf Christiane M.

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1247-1266

Adis International

Access to resources Recommend Favorite

Clinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor

By Bannwarth Bernard Berenbaum Francis

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 4, 2005-04 ,pp. : 521-533

Informa Healthcare

Access to resources Recommend Favorite

Balancing Gastroprotection and Cardioprotection with Selective Cyclo-Oxygenase-2 Inhibitors: Clinical Implications

By Meagher E.A.

Drug Safety, Vol. 26, Iss. 13, 2003-01 ,pp. : 913-924

Adis International

Access to resources Recommend Favorite